DongKook Pharmaceutical Co., Ltd.
Financials
Valuation Metrics
DongKook Pharmaceutical Co., Ltd.'s Market Cap is ₩1.1T. At end of 2025 it was ₩7757B. Ranked #288 of 2,405 in KR market (top 12%), #75 of 1,627 on KOSDAQ (top 5%), #30 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 13%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 1.07T KRW | KR#288/2,405 Sec#30/231 |
| Revenue | 979.60B KRW | KR#418/2,405 Sec#15/231 |
| Net Income | 81.46B KRW | KR#288/2,405 Sec#18/231 |
| Total Assets | 1.12T KRW | KR#452/2,405 Sec#24/231 |
| Net Assets | 797.63B KRW | KR#348/2,405 Sec#21/231 |
| Employees | 1,216 | KR#211/2,405 Sec#13/231 |
| Value | ||
| P/E | 13.13x | KR#1,020/2,405 Sec#58/231 |
| P/B | 1.34x | KR#1,751/2,405 Sec#122/231 |
| PEG | 0.48x | KR#697/2,405 Sec#44/231 |
| P/S | 1.09x | KR#1,493/2,405 Sec#86/231 |
| EV/EBITDA | 10.36x | KR#681/2,405 Sec#32/231 |
| FCF Yield | 2.43% | KR#1,038/2,405 Sec#67/231 |
| Profitability | ||
| ROE | 10.21% | KR#595/2,405 Sec#42/231 |
| ROA | 7.29% | KR#490/2,405 Sec#37/231 |
| Op. Margin | 10.47% | KR#496/2,405 Sec#44/231 |
| Revenue Growth | 12.73% | KR#766/2,405 Sec#75/231 |
| Earnings Growth | 27.37% | KR#664/2,405 Sec#44/231 |
| Financial Health | ||
| Debt Ratio | 40.12% | KR#786/2,405 Sec#92/231 |
| Total Debt | 67.26B KRW | KR#884/2,405 Sec#60/231 |
| FCF | 26.05B KRW | KR#447/2,405 Sec#26/231 |
| Cash | 74.46B KRW | KR#582/2,405 Sec#30/231 |
| Current Ratio | 2.05x | KR#841/2,405 Sec#95/231 |
| Net Debt/EBITDA | -0.07x | KR#586/2,405 Sec#35/231 |
| Dividend | ||
| Div. Yield | 0.85% | KR#1,177/2,405 Sec#70/231 |
| Div. Growth | 0.00% | KR—/2,405 Sec—/231 |
| Performance | ||
| 1Y Return | 33.77% | KR#242/2,405 Sec#11/231 |
| 1M Return | 3.96% | KR#186/2,405 Sec#19/231 |
| From 52W High | -24.32% | KR#279/2,405 Sec#15/231 |
| 1Y MDD | -44.68% | KR#733/2,405 Sec#54/231 |
| Trading | ||
| Volume | 310,399 shares | KR#253/2,405 Sec#16/231 |
| Trading Value | 7.36B KRW | KR#245/2,405 Sec#17/231 |
| Foreign Own. | 10.97% | KR#443/2,405 Sec#37/231 |
| Per Share | ||
| EPS | 1,801 KRW | KR#484/2,405 Sec#29/231 |
| BPS | 17,635 KRW | KR#599/2,405 Sec#39/231 |
Company Info
Dongguk Pharmaceutical, established in 1968 and listed on KOSDAQ in 2007, is a pharmaceutical company with subsidiaries including Dongguk Pharmaceutical Life Science. It manufactures and sells over-the-counter drugs, prescription drugs, and active pharmaceutical ingredients, alongside supplying cosmetics, health functional foods, and household goods domestically and internationally. The company has built a strong production base through mass production of natural material ingredients, automated warehouses, and secure manufacturing spaces. It is expanding into a global pharmaceutical company by exporting new platform technology products overseas. The company is headquartered in Gangnam-gu, Seoul.